Vigano Paul R's Form 4 filing
Aveanna Healthcare Holdings, Inc. (AVAH) · filed Apr 3, 2025
- Accession no.
- 0000950170-25-050718
- Filed
- Apr 3, 2025
- Trade date
- Apr 1-2, 2025
- Filing delay
- 2 days
- Rule 10b5-1 plan
- Checked
This filing lists 10 non-derivative transactions. Open-market sales total $114.4K. It was filed 2 days after the trade.
Reporting owners
A Form 4 can have several reporting owners, such as a person and a fund they control. Trade tables show the first one.
| Owner | Relationship to the company |
|---|---|
| Vigano Paul RCIK 0001239606 | 10% Owner |
Non-derivative securities (Table I)
Acquisitions and disposals of common stock and similar shares, one row per line on the filing.
| Trade date | Security | Transaction | Shares | Price | Value | Shares after | Ownership | Flags |
|---|---|---|---|---|---|---|---|---|
| Apr 1, 2025 | Common Stock, $0.01 par value | SSaleDisposed | −3,610 | $5.63F2 | −$20,324.3 | 31,384,260 | Indirect | |
| Apr 2, 2025 | Common Stock, $0.01 par value | SSaleDisposed | −8,166 | $5.63F3 | −$45,974.58 | 31,376,094 | Indirect | |
| Apr 1, 2025 | Common Stock, $0.01 par value | SSaleDisposed | −1,803 | $5.63F2 | −$10,150.89 | 15,679,913 | Indirect | |
| Apr 2, 2025 | Common Stock, $0.01 par value | SSaleDisposed | −4,080 | $5.63F3 | −$22,970.4 | 15,675,833 | Indirect | |
| Apr 1, 2025 | Common Stock, $0.01 par value | SSaleDisposed | −559 | $5.63F2 | −$3,147.17 | 5,212,447 | Indirect | |
| Apr 2, 2025 | Common Stock, $0.01 par value | SSaleDisposed | −1,356 | $5.63F3 | −$7,634.28 | 5,211,091 | Indirect | |
| Apr 1, 2025 | Common Stock, $0.01 par value | SSaleDisposed | −167 | $5.63F2 | −$940.21 | 1,451,598 | Indirect | |
| Apr 2, 2025 | Common Stock, $0.01 par value | SSaleDisposed | −378 | $5.63F3 | −$2,128.14 | 1,451,220 | Indirect | |
| Apr 1, 2025 | Common Stock, $0.01 par value | SSaleDisposed | −63 | $5.63F2 | −$354.69 | 546,389 | Indirect | |
| Apr 2, 2025 | Common Stock, $0.01 par value | SSaleDisposed | −142 | $5.63F3 | −$799.46 | 546,247 | Indirect |
Footnotes and remarks
Livermore keeps the footnotes that transaction prices refer to, all footnotes of amendments (Form 4/A) and the filing's remarks. Other footnotes, such as how indirect holdings are held or the details of a trading plan, are only in the original on SEC EDGAR.
- F2
The price reported in Column 4 is a weighted average price. The shares were sold in multiple transactions at prices ranging from $5.62 to $5.67. The reporting persons hereby undertake to provide, upon request, to the staff of the Securities and Exchange Commission ("SEC"), the Issuer, or any security holder of the Issuer, full information regarding the number of shares sold at each separate price within the range set forth in this footnote (2) to this Form 4.
Referenced by the price of 5 transactions in Table I.
- F3
The price reported in Column 4 is a weighted average price. The shares were sold in multiple transactions at prices ranging from $5.62 to $5.65. The reporting persons hereby undertake to provide, upon request, to the staff of the SEC, the Issuer, or any security holder of the Issuer, full information regarding the number of shares sold at each separate price within the range set forth in this footnote (3) to this Form 4.
Referenced by the price of 5 transactions in Table I.